CD163 and neoplasm: For example, chemotherapy-treated MYCN-amplified neuroblastoma patients showed increased tumor infiltration of HLA-DR+, CD11c+, CD68+, and CD14+ pro-tumorigenic macrophages that expressed immunosuppressive molecules such as Tim-3, B7-H3, and CD163 [26].